The Most Popular Phase of Product Development for Starting Medical Publications Activities

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 14, 2017) - A new study by business intelligence provider Cutting Edge Information found that the highest percentage of surveyed life science teams (30%) delay medical publications activities until products enter the registration and launch phase of product development.

The study, Planning Medical Abstracts and Manuscripts, analyzed pharmaceutical, biotech and device company teams to discover current and upcoming trends in the medical affairs space, and found that a quarter (25%) of surveyed teams report planning and executing publication strategies during Phase 3a and 3b.

"Medical publications are a critical piece of a successful medical affairs launch strategy," said Natalie DeMasi, research team leader at Cutting Edge Information. "Generally speaking, publications activities start one year before launch, but ultimately, how companies coordinate publications activities is largely dependent on team level, product type and product lifecycle."

The same Cutting Edge Information study found that few surveyed life science teams begin medical publications work earlier than Phase 2 of product development. During Phase 2 itself, 19% of pharmaceutical companies reported starting publications activities.

Survey data indicate that a smaller percentage (13%) of medical affairs groups may not develop publications materials until after products have reached the marketplace.

Planning Medical Abstracts and Manuscripts, available online at, provides data about medical publications teams' resources and activity levels throughout launch window. The report presents profiles outlining how teams supporting common, niche or blockbuster products execute their publications strategies. In developing this research, Cutting Edge Information's analysts collected surveys from and consulted with medical affairs leaders at top pharmaceutical, biotechnology and medical device companies.

Planning Medical Abstracts and Manuscripts is part of a 10-part series that Cutting Edge Information will be publishing throughout 2017. The Medical Affairs Product Launch Series, available at, investigates how medical affairs resources and key performance indicators (KPIs) shift between two years prior to launch, one year before launch, launch year and during the product's first year on market.

Image Available:

Contact Information:

Elio Evangelista
Senior Director of Commercialization
Cutting Edge Information

medical publications, medical affairs